Data: Lucid-MS seen to be safe, well tolerated in healthy volunteers
FSD Pharmaās Lucid-21-302 ā an oral treatment candidate known as Lucid-MS, for all types of multiple sclerosis (MS) ā was found safe and well tolerated across multiple doses in healthy volunteers, according to interim data from a Phase 1 clinical trial. The newly released data are from the…